1. Market Research
  2. > Healthcare Market Trends
  3. > United Kingdom Pharmaceuticals and Healthcare Report Q3 2016

United Kingdom Pharmaceuticals and Healthcare Report Q3 2016

  • July 2016
  • -
  • Business Monitor International
  • -
  • 105 pages

Includes 3 FREE quarterly updates

BMI View: The rate of investment in pharmaceutical and biomedicine R&D in the UK will remainsignificantly high. Meanwhile, our earlier view on upside risks to healthcare spending has started tomaterialise, with the latest data leading us to revise upwards the UK healthcare market forecast, in partowing to an increased health budget. However, the uncertainty following the Brexit vote undermines theoutlook and prospects for the sector.Headline Expenditure Projections

- Pharmaceuticals: GBP26.20bn (USD40.04bn) in 2015 to GBP26.79bn (USD38.28bn) in 2016; +2.3%in local currency terms and -4.4% in US dollar terms. Forecast in line with last quarter.

- Healthcare: GBP157.77bn (USD241.10bn) in 2015 to GBP162.26bn (USD231.80bn) in 2016; +2.9% inlocal currency terms and -3.9% in US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

United Kingdom Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (United Kingdom 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (United Kingdom 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United Kingdom 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United Kingdom 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United Kingdom 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United Kingdom 2012-2020) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United Kingdom 2012-2020) 24
Generic Drug Market Forecast 25
OTC Medicine Market Forecast 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United Kingdom 2012-2020) 30
Pharmaceutical Trade Forecast 31
Table: Pharmaceutical Trade Data And Forecasts (United Kingdom 2014-2020) 33
Table: Pharmaceutical Trade Data And Forecasts local currency (United Kingdom 2014-2020) 33
Industry Risk Reward Indices 34
Western Europe Risk/Reward Index 34
United Kingdom Risk/Reward Index 39
Rewards 39
Risks 40
Regulatory Review 41
Intellectual Property Issues 43
Pricing Regime 45
Reimbursement Regime 51
Market Overview 54
Healthcare Sector 55
Table: Healthcare Resources (United Kingdom 2010-2015) 60
Table: Healthcare Personnel (United Kingdom 2010-2015) 60
Table: Healthcare Activity (United Kingdom 2010-2015) 61
Research And Development 61
Clinical Trials 63
Epidemiology 64
Competitive Landscape 67
Research-Based Industry 67
Table: Leading Pharmaceutical Corporations' UK Market Share, 2014 67
Table: Multinational Market Activity 70
Pharmaceutical Distribution 71
Pharmaceutical Retail Sector 72
Table: UK-Registered Retail Pharmacies, 2010 73
Company Profile 74
GlaxoSmithKline 74
AstraZeneca 80
Pfizer 85
Novartis 88
Sanofi 91
Demographic Forecast 94
Table: Population Headline Indicators (United Kingdom 1990-2025) 95
Table: Key Population Ratios (United Kingdom 1990-2025) 95
Table: Urban/Rural Population and Life Expectancy (United Kingdom 1990-2025) 96
Table: Population By Age Group (United Kingdom 1990-2025) 96
Table: Population By Age Group % (United Kingdom 1990-2025) 97
Glossary 99
Methodology 101
Pharmaceutical Expenditure Forecast Model 101
Healthcare Expenditure Forecast Model 101
Notes On Methodology 102
Risk/Reward Index Methodology 103
Index Overview 104
Table: Pharmaceutical Risk/Reward Index Indicators 104
Indicator Weightings 105

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Wound Care Market by Product, Surgical, Traditional, Wound Type, Acute, End User, Long-Term Care, Home Healthcare - Global Forecast to 2021

Wound Care Market by Product, Surgical, Traditional, Wound Type, Acute, End User, Long-Term Care, Home Healthcare - Global Forecast to 2021

  • $ 7 150
  • Industry report
  • May 2016
  • by MarketsandMarkets

The wound care market in terms of value is expected to reach USD 20.4 billion by 2021 from USD 17.0 billion in 2016, growing at a CAGR of 3.6% from 2016 to 2021. This market is categorized on the basis ...

Psoriatic Arthritis Pricing, Reimbursement, and Access

Psoriatic Arthritis Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • June 2016
  • by Datamonitor Healthcare

An absence of head-to-head trials, along with biosimilar launches, provide payers with leverage to demand favorable pricing for branded products in exchange for formulary access. This report addresses ...

Adhesion Barrier Market by Product, Product Form, Application - Global Forecast to 2021

Adhesion Barrier Market by Product, Product Form, Application - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global adhesion barriers market is expected to grow at a CAGR of 8.4% during the forecast period of 2016 to 2021. This market is projected to reach USD 1,216.8 million by 2021 from USD 812.5 million ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.